GLP-1 receptor agonists in modern therapeutics

Download the article to explore the mechanisms, therapeutic applications, and future directions of GLP-1 receptor agonists in precision medicine.

Name(Required)

Full name

Email(Required)

Company(Required)

Single Cell Discoveries Acquires TATAA Biocenter to Create an End-to-End Precision Biology CRO
TATAA Biocenter is now part of Single Cell Discoveries. We continue to operate from Gothenburg with the same team, the same accreditations, and the same points of contact. What's new is access to SCD's single-cell and spatial discovery capabilities alongside our regulated bioanalysis. Read the full announcement.